Cambridge Healthtech Institute’s Inaugural

Artificial Intelligence for Drug Discovery & Development

Applications From Drug Design to Clinical Trials

March 19, 2020

 

This focused one-day symposium on Artificial Intelligence (AI) for Drug Discovery & Development will bring together scientists, clinicians and executives from early discovery, DMPK/toxicology, clinical trial management and other parts of the drug pipeline to talk about the increasing use of analytics, including AI, machine learning (ML), and data mining. The symposium will introduce attendees to how AI is being applied in drug discovery and development and highlight the application of advanced concepts with relevant case studies and research findings.     

 

Coverage will include, but is not limited to:

 

  • Applications of AI:
    • Drug design and lead optimization
    • Target identification and validation
    • Disease modeling and mechanisms of action
    • Defining genotypes and phenotypes
    • Adverse events and drug toxicity
    • Patient stratification and response
    • Drug combinations and repositioning
  • Case studies elaborating how AI/ML can help drug discovery and precision medicine
  • Understanding limitations and caveats when using AI/ML Predictions
  • AI/ML vs deep learning in drug development, correlation vs causality?
  • How is AI/ML addressing real-world healthcare problems?

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is September 9th 2020.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute
Email: tkoppal@healthtech.com

 

For partnering and sponsorship information, please contact:

Carolyn Cooke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5412
Email: ccooke@healthtech.com


Oligonucleotide Discovery and Delivery